The Department of Clinical Pharmacology, Lund University Hospital, Lund, Sweden For many years, antimuscarinic drugs have been the first-line pharmacological treatment for urgency, frequency, and urge ...

Chicago, IL (UroToday.com) The AUA and SUFU initially released a joint guideline for non-neurogenic overactive bladder (OAB) in 2012 ... Vasavada notes that the guidelines do not require that every ...

can help relax an overactive bladder. But the drugs have been linked to serious side effects, including dementia, and they’re no longer a wise first choice for treatment. “The older you are ...

Millions of people in the United States struggle with overactive bladder ... You may try one treatment alone, or several at the same time. You and your health care team should talk about what you want ...

An important question is how PTNS compares with the established alternatives for the treatment of overactive bladder. Established treatments would include non-pharmacologic measures such as ...

Antimuscarinic treatment at regular doses fails to completely alleviate symptoms in approximately 40% of patients with overactive or neurogenic bladder. With this in mind, Bolduc et al. 3 have ...

In summary, PTNS is a noninvasive treatment for OAB and it has been shown to be useful in reducing overactive bladder symptoms when given weekly for 12 weeks. Improvement has been seen in ...